The global biopharmaceuticals market is witnessing extraordinary transformation, projected to expand from USD 616.9 billion in 2024 to over USD 1.18 trillion by 2032, reflecting a compound annual growth rate (CAGR) of approximately 8.6%. Another forecast places it at USD 918.8 billion by 2033, driven by demand for targeted therapies, rising chronic disease prevalence, and breakthrough...
The global Pharmaceutical Mass Flow Controller Market is entering a transformative era, powered by heightened demand for precision fluid control, ongoing automation across pharmaceutical manufacturing, and regulatory push for quality assurance. With a surge in biologics, personalized medicines, and complex drug formulations, the need for highly accurate, real-time mass flow control devices is...
The global Recombinant DNA (rDNA) Technology Market is on track to grow from an estimated USD 798 billion in 2023 to USD 1,395 billion by 2032, registering a steady compound annual growth rate (CAGR) of 6.4%. The market is being propelled by expanding applications in pharmaceuticals, agriculture, industrial biotechnology, and environmental sustainability.
Market Snapshot
2023 Market Size:...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek